Finance

Lists
Why is 002566 down 2,04%?
Dive Deeper
002566:SHE
Jilin Jian Yisheng Pharmaceutical Co Ltd
CNÂ¥6,71
-2,04%
(-0,14) 1D
15 Okt., 14:48:06 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002566...
Open
CNÂ¥6,80
High
CNÂ¥6,85
Low
CNÂ¥6,68
Mkt. cap
2,32 mjd
Avg. vol.
6,84 m
Volume
5,73 m
Dividend
1,19%
Quarterly dividend
CNÂ¥0,02
Ex-dividend date
29 Mei 2026
P/E ratio
59,91
52-wk high
CNÂ¥9,68
52-wk low
CNÂ¥5,76
EPS
CNÂ¥0,11
Shares outstanding
330,95 m
No. of employees
2 k
Open
CNÂ¥6,80
High
CNÂ¥6,85
Low
CNÂ¥6,68
Mkt. cap
2,32 mjd
Avg. vol.
6,84 m
Volume
5,73 m
Dividend
1,19%
Quarterly dividend
CNÂ¥0,02
Ex-dividend date
29 Mei 2026
P/E ratio
59,91
52-wk high
CNÂ¥9,68
52-wk low
CNÂ¥5,76
EPS
CNÂ¥0,11
Shares outstanding
330,95 m
No. of employees
2 k
News stories
From web sources and news partners
About Jilin Jian Yisheng Pharmaceutical Co Ltd
CEO-
Employees1,62 k
Founded11 Jun. 1997
Headquarters-
SectorPharmaceutical industry
Websiteyisheng-pharm.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
148,37 m
163,98 m
178,61 m
159,87 m
Cost of goods sold
37,05 m
51,97 m
44,72 m
40,73 m
Cost of revenue
37,05 m
51,97 m
44,72 m
40,73 m
Research and development expenses
3,52 m
3,58 m
4,54 m
4,01 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
97,33 m
105,49 m
115,30 m
105,16 m
Operating expense
110,81 m
113,25 m
125,70 m
114,52 m
Total operating expenses
147,86 m
165,23 m
170,42 m
155,25 m
Operating income
510,34 k
-1,25 m
8,19 m
4,62 m
Other non operating income
393,57 k
-640,61 k
-39,52 k
46,60 k
EBT including unusual items
5,35 m
2,24 m
18,90 m
13,23 m
EBT excluding unusual items
-2,30 m
-2,76 m
8,20 m
10,96 m
Income tax expense
756,21 k
-2,27 m
2,68 m
1,62 m
Effective tax rate
14,14%
-101,06%
14,18%
12,27%
Other operating expenses
9,69 m
3,89 m
3,88 m
3,58 m
Net income
5,36 m
4,87 m
16,14 m
10,69 m
Net profit margin
3,62%
2,97%
9,04%
6,68%
Earnings per share
-
-
-
-
Interest and investment income
194,61 k
1,83 m
3,14 m
9,02 m
Interest expense
-3,40 m
-2,70 m
-3,09 m
-2,73 m
Net interest expenses
-3,20 m
-871,44 k
55,92 k
6,29 m
Depreciation and amortization charges
-
-
-
-
EBITDA
11,16 m
8,38 m
17,81 m
14,24 m
Gain or loss from assets sale
282,36 k
-400,97 k
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme